Embedded Files
WE stratify IMMUNOTHERAPY clinical trials
WE stratify IMMUNOTHERAPY clinical trials
Our mission is to accelerate the development of effective cancer therapies by enabling smarter, more precise clinical trials. We provide predictive AI technology that helps pharma and biotech partners stratify patients and design studies that bring treatments to those who need them faster.
Smarter trials. Faster therapies. Better patient outcomes.
Smarter trials. Faster therapies. Better patient outcomes.
OUR ORIGINS
OUR ORIGINS
Glass Medical AI is a tech-bio spin-out created by the University of Amsterdam, built on five years of academic R&D. We develop predictive AI technology to transform oncology drug development. We are united by one goal: delivering the right treatment to the right patient, smarter and faster.
OUR TECHNOLOGY
OUR TECHNOLOGY
We develop predictive AI pipelines that accelerate oncology drug development and improve patient selection. Our technology supports rapid patient stratification and trial design across a wide range of cancer indications, enabling breakthrough therapies such as checkpoint inhibitors, CAR-T, and TIL therapies to reach patients smarter and faster.
OUR PROMISE
OUR PROMISE
We are committed to helping our partners design better trials, reduce development risk, and deliver the right treatments to the right patients smarter and faster. By combining world-class AI with deep medical expertise, we turn innovation into better patient outcomes.
THE EXECUTIVE TEAM
We combine deep scientific, medical, and business expertise with a proven track record in pharma, biotech, and AI. From launching blockbuster drugs and leading AI breakthroughs to advancing precision oncology and healthcare innovation, we bring together world-class leaders.
RICHARD
STOKVIS
MD
THE VISIONARY
CEO & Chairman Pharma veteran, Consultant, Investment Banker, who also likes to get his hands dirty.
ALI
BAHRAMISHARIF
PhD
THE BUILDER
CTO & Executive Director, AI and neuroscience expert, former professor with three successful company exits.
ISABELL
VON LOGA
MD PhD
THE STRATEGIST
Lead Corporate Business Development, physician-scientist and strategist
(ex-Monitor Deloitte) driving life science innovation.
CHRISTIAN
BLANK
MD PhD
THE PIONEER
World-renowned pioneer in melanoma immunotherapy. His landmark trials established neo-adjuvant immuno-therapy as a new SoC, transforming treatment prediction and outcomes.
JONAS
TEUWEN
PhD
THE INNOVATOR
Professor and group Leader of the AI for Oncology Lab at the Netherlands Cancer Institute, advancing novel AI to identify responders, transform cancer diagnosis and improve treatment prediction.
HUGO
HORLINGS
MD PhD
THE TRANSLATOR
Pathologist and Group Leader at the Netherlands Cancer Institute, pioneering computational pathology for precision cancer care.
OUR ADVISORS
We are proud to be guided by a team of world-class advisors whose expertise spans oncology, immunotherapy, neuroscience, biotech leadership, and global drug development. From leading cancer immunotherapy research at the Netherlands Cancer Institute to driving integration at big pharma companies, to serving as CEOs and CMOs of major life science companies, our advisors bring unparalleled scientific, clinical, and strategic insight. Their belief in Glass Medical AI underscores both the potential of our technology and our shared mission: to transform how cancer therapies are developed and delivered.
HQ, R&D office
HQ, R&D office
Roetersstraat 35
1018WB Amsterdam
Netherlands
KVK: 97365041
Commercial office
Commercial office
Picassoplatz 4
4052 Basel
Switzerland
UID: CHE-438.330.531
Page updated
Report abuse